OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4936$332.0059

AXXZIA Inc

Personal ProductsVerified

AXXZIA Inc maintains a strong liquidity position, with cash and equivalents of ¥3.99 billion, representing 41.7% of total assets. The company’s price-to-book ratio is 1.0, and its debt-to-equity ratio is 0.11, indicating a conservative capital structure with minimal leverage. The current ratio of 4.37 further supports its ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 4.23% and a return on assets (ROA) of 3.35%, both below the typical thresholds for high-performing personal care firms. The operating margin is 3.77% (¥507.55 million operating income on ¥13.48 billion revenue), and the net margin is 2.38% (¥320.66 million net income on ¥13.48 billion revenue), suggesting moderate efficiency in converting revenue to profit. The company’s revenue is concentrated in a single business segment, the Cosmetics Business, which accounts for 100% of total revenue. Geographically, the company operates primarily in Japan, with no disclosed international revenue breakdown, indicating a high concentration risk. Revenue growth appears stable, with the most recent fiscal year reporting ¥13.48 billion in revenue. Analysts estimate revenue for the next fiscal year at ¥13.55 billion, representing a 0.5% year-over-year increase. The company’s capital expenditures of ¥162.33 million were primarily used for operational expansion, and free cash flow was negative at ¥16.86 million, indicating reinvestment into the business. Risk factors are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and its capital structure remains stable with no near-term dilution pressure. Recent events include consistent performance relative to analyst estimates, with actual EPS of ¥15.18 exceeding the mean estimate of ¥6.60. The company’s market price of ¥332 supports a price-to-earnings ratio of 23.68, which is in line with the broader personal care sector.

30-day price · 4936-19.00 (-5.5%)
Low$326.00High$363.00Close$326.00As of18 May, 00:00 UTC
Profile
CompanyAXXZIA Inc
Ticker4936.T
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. AXXZIA Inc is a Japan-based company engaged in the manufacture and sale of cosmetics and health supplements, generating revenue through direct sales to beauty salon operators, general consumers, and wholesale channels.

Classification. AXXZIA Inc is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry, with a confidence level of 0.92.

AXXZIA Inc maintains a strong liquidity position, with cash and equivalents of ¥3.99 billion, representing 41.7% of total assets. The company’s price-to-book ratio is 1.0, and its debt-to-equity ratio is 0.11, indicating a conservative capital structure with minimal leverage. The current ratio of 4.37 further supports its ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 4.23% and a return on assets (ROA) of 3.35%, both below the typical thresholds for high-performing personal care firms. The operating margin is 3.77% (¥507.55 million operating income on ¥13.48 billion revenue), and the net margin is 2.38% (¥320.66 million net income on ¥13.48 billion revenue), suggesting moderate efficiency in converting revenue to profit. The company’s revenue is concentrated in a single business segment, the Cosmetics Business, which accounts for 100% of total revenue. Geographically, the company operates primarily in Japan, with no disclosed international revenue breakdown, indicating a high concentration risk. Revenue growth appears stable, with the most recent fiscal year reporting ¥13.48 billion in revenue. Analysts estimate revenue for the next fiscal year at ¥13.55 billion, representing a 0.5% year-over-year increase. The company’s capital expenditures of ¥162.33 million were primarily used for operational expansion, and free cash flow was negative at ¥16.86 million, indicating reinvestment into the business. Risk factors are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and its capital structure remains stable with no near-term dilution pressure. Recent events include consistent performance relative to analyst estimates, with actual EPS of ¥15.18 exceeding the mean estimate of ¥6.60. The company’s market price of ¥332 supports a price-to-earnings ratio of 23.68, which is in line with the broader personal care sector.
Key takeaways
  • AXXZIA Inc maintains a conservative capital structure with a low debt-to-equity ratio of 0.11 and strong liquidity.
  • The company’s profitability is moderate, with ROE and ROA below industry benchmarks.
  • Revenue is entirely concentrated in the Cosmetics Business segment, with no disclosed international diversification.
  • Analysts expect minimal revenue growth in the next fiscal year, with a projected 0.5% increase.
  • The company has no immediate liquidity or dilution risks, and its capital expenditures suggest reinvestment in operations.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$13.48B
Gross profit$9.87B
Operating income$507.6M
Net income$320.7M
R&D
SG&A
D&A
SBC
Operating cash flow$781.7M
CapEx-$162.3M
Free cash flow-$16.9M
Total assets$9.57B
Total liabilities$2.00B
Total equity$7.57B
Cash & equivalents$3.99B
Long-term debt$860.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$332.00
Market cap$7.59B
Enterprise value$4.46B
P/E23.7
Reported non-GAAP P/E
EV/Revenue0.3
EV/Op income8.8
EV/OCF5.7
P/B1.0
P/Tangible book1.0
Tangible book$7.57B
Net cash$3.13B
Current ratio4.4
Debt/Equity0.1
ROA3.4%
ROE4.2%
Cash conversion2.4%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric4936Activity
Op margin3.8%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin2.4%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin73.3%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-1.2%-2.3% medp25 -4.4% · p75 -1.1%above median
Debt / equity11.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Mean EPS estimate6.60 JPY
Last actual EPS15.18 JPY
Mean revenue estimate13,550,000,000 JPY
Last actual revenue13,479,890,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:00 UTC#5fed676e
Market quoteclose JPY 332.00 · shares 0.02B diluted
no public URL
2026-05-10 03:00 UTC#80429214
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:02 UTCJob: ca4fc140